Search Results
38 Results for 'Drug production & design'
PAGE 2 OF 2
Technology
Better Living Through Peptides; Improved Approach to HIV Therapy
Human immunodeficiency virus (HIV) affects over 1.2 million Americans each year, with approximately 50,000 new infections per year. Current treatment includes HIV combination regimens comprising rever...
Learn More
Learn More
Samuel Gellman, William Horne, Lisa Johnson | P08414US03
Technology
New System for Producing Fungal Secondary Metabolites
Fungi produce a variety of chemical compounds called secondary metabolites that possess useful pharmaceutical properties. These compounds are invaluable platforms for developing front-line drugs. They...
Learn More
Learn More
Nancy Keller, Philipp Wiemann | P150029US02
Technology
Peptide Mimics Last Longer, Target Protein-Protein Interactions
The ability to modulate interactions between proteins is an attractive goal for both research and therapeutic applications. Developing modulating agents using traditional small-molecule approaches is ...
Learn More
Learn More
Samuel Gellman, James Checco | P140148US02
Technology
Increasing Secondary Metabolite Production in Fungus for Drug Development
Fungi produce a variety of chemical compounds called secondary metabolites. These compounds display a broad range of activities, including fighting off other fungi and bacteria. They also are useful f...
Learn More
Learn More
Nancy Keller, Jin Woo Bok | P130203US01
Technology
Easier, More Flexible Synthesis of Therapeutic and Promising Compounds
Many pharmaceuticals and other biologically active molecules contain chemical sequences called triads that are challenging to prepare in the laboratory. Specifically, triads are three or more contiguo...
Learn More
Learn More
Jennifer Schomaker, Luke Boralsky, John Hershberger, Jared Rigoli, Christopher Adams | P110299US02
Technology
Safer Influenza Vaccine from Replication-Knock Out Virus
Influenza viruses instigate annual global epidemics. The first influenza pandemic in 40 years occurred during the 2009-2010 season, when a novel H1N1 strain emerged and spread worldwide. The United St...
Learn More
Learn More
Yoshihiro Kawaoka, Gabriele Neumann, Makoto Ozawa | P110003US02
Technology
Improved Asymmetric Hydroformylation of Therapeutics Using Novel Bisphosphines
Asymmetric synthesis is important in the pharmaceutical industry because frequently only one optically active isomer, or enantiomer, is therapeutically active. Therefore, it is often desirable to sele...
Learn More
Learn More
Clark Landis, Thomas Clark, Jerzy Klosin | P04447US
Technology
Method for Assessing 3-D Crystal Structures from in Situ Digital Images
Suspension crystallization processes often result in crystals with a wide range of particle sizes. Accurately controlling the distribution of shapes and sizes is a challenge in the pharmaceutical ma...
Learn More
Learn More
James Rawlings, Nicola Ferrier, Paul Larsen | P06449US
Technology
Microfluidics Platform and Method That Mimic the Cellular Environment
Most biochemical interactions are studied in solutions containing dilute concentrations of molecules. However, the complexity of the cellular environment makes it difficult to compare the results of s...
Learn More
Learn More
David Beebe, Jaisree Moorthy, Richard Burgess | P04153US
Technology
Biosynthetic Gene Cluster That Produces the Natural Antibiotics Platensimycin and Platencin
As the incidence of antibiotic resistance among bacteria continues to rise, the discovery of new antibacterial compounds has become increasingly critical to fighting infectious disease. According to t...
Learn More
Learn More
Ben Shen, Michael Smanski | P07515US
Technology
Recombinant Influenza Viruses for Vaccines and Gene Therapy
Influenza viruses show strong potential as vaccine and gene delivery vectors: they do not replicate through DNA intermediates (which may incorporate into the host genome); they elicit strong immune re...
Learn More
Learn More
Yoshihiro Kawaoka, Gabriele Neumann | P99264US
Technology
VeA, a Global Regulator of Secondary Metabolism, Can Increase Production of Secondary Metabolites
Microorganisms, such as fungi, produce a variety of secondary metabolites. These secondary metabolites display a broad range of activities, including antibiotic, immunosuppressant, phytotoxic and my...
Learn More
Learn More
Nancy Keller, Saori Campen | P09056US02
Technology
Type 1 Polyketide Synthase Extender Units
Microorganisms produce a variety of biologically active secondary metabolites, which display a range of useful antibiotic and immunosuppressant activities. One class of secondary metabolites, known as...
Learn More
Learn More
Michael Thomas, Jo Handelsman, Yolande Chan, Angela Podevels | P06464US